The post Ritz Crackers Recalled In Eight States Over Peanut Allergy Threat appeared on BitcoinEthereumNews.com. Topline Dozens of cases of Ritz Peanut Butter Cracker Sandwich were recalled this week after individually wrapped packs were possibly mislabeled as the cheese variety of the cracker sandwiches, according to the Food and Drug Administration, impacting eight states. Photos of the impacted products (not pictured) can be seen on the FDA’s website. Photo by Kevin Carter/Getty Images Key Facts A total of 70 cases of the peanut butter cracker sandwiches have been recalled after individually wrapped packs “may” have been mislabeled as Ritz Cheese Cracker Sandwiches, the FDA said in a statement. All outer cartons of the affected cases are labeled correctly with allergen information that says the product contains peanuts. The products included in the recall are 20 pack units that contain six-piece sleeves and have “best when used by” dates of Jan. 8, 2026 and Jan. 15, 2026. The items also have an “AE” plant code on top of the package. Photos of the impacted units can be seen on the FDA’s website, which says they were available at a limited number of retail stores as of Nov. 28. The cases were sold in New York, New Jersey, Pennsylvania, Georgia, Arkansas, Missouri, Oklahoma, and Alabama. No injuries or illness were reported to Mondelēz Global, the parent company of Ritz, as of Nov. 28. Get Forbes Breaking News Text Alerts: We’re launching text message alerts so you’ll always know the biggest stories shaping the day’s headlines. Text “Alerts” to (201) 335-0739 or sign up here. Big Number 4.6 million. That is approximately how many Americans have peanut allergies, according to a 2021 study in the Journal of Allergy and Clinical Immunology. Read More Source: https://www.forbes.com/sites/antoniopequenoiv/2025/12/03/ritz-cracker-sandwiches-recalled-after-mislabeling-poses-threat-to-those-with-peanut-allergies/The post Ritz Crackers Recalled In Eight States Over Peanut Allergy Threat appeared on BitcoinEthereumNews.com. Topline Dozens of cases of Ritz Peanut Butter Cracker Sandwich were recalled this week after individually wrapped packs were possibly mislabeled as the cheese variety of the cracker sandwiches, according to the Food and Drug Administration, impacting eight states. Photos of the impacted products (not pictured) can be seen on the FDA’s website. Photo by Kevin Carter/Getty Images Key Facts A total of 70 cases of the peanut butter cracker sandwiches have been recalled after individually wrapped packs “may” have been mislabeled as Ritz Cheese Cracker Sandwiches, the FDA said in a statement. All outer cartons of the affected cases are labeled correctly with allergen information that says the product contains peanuts. The products included in the recall are 20 pack units that contain six-piece sleeves and have “best when used by” dates of Jan. 8, 2026 and Jan. 15, 2026. The items also have an “AE” plant code on top of the package. Photos of the impacted units can be seen on the FDA’s website, which says they were available at a limited number of retail stores as of Nov. 28. The cases were sold in New York, New Jersey, Pennsylvania, Georgia, Arkansas, Missouri, Oklahoma, and Alabama. No injuries or illness were reported to Mondelēz Global, the parent company of Ritz, as of Nov. 28. Get Forbes Breaking News Text Alerts: We’re launching text message alerts so you’ll always know the biggest stories shaping the day’s headlines. Text “Alerts” to (201) 335-0739 or sign up here. Big Number 4.6 million. That is approximately how many Americans have peanut allergies, according to a 2021 study in the Journal of Allergy and Clinical Immunology. Read More Source: https://www.forbes.com/sites/antoniopequenoiv/2025/12/03/ritz-cracker-sandwiches-recalled-after-mislabeling-poses-threat-to-those-with-peanut-allergies/

Ritz Crackers Recalled In Eight States Over Peanut Allergy Threat

2025/12/04 07:52

Topline

Dozens of cases of Ritz Peanut Butter Cracker Sandwich were recalled this week after individually wrapped packs were possibly mislabeled as the cheese variety of the cracker sandwiches, according to the Food and Drug Administration, impacting eight states.

Photos of the impacted products (not pictured) can be seen on the FDA’s website.

Photo by Kevin Carter/Getty Images

Key Facts

A total of 70 cases of the peanut butter cracker sandwiches have been recalled after individually wrapped packs “may” have been mislabeled as Ritz Cheese Cracker Sandwiches, the FDA said in a statement.

All outer cartons of the affected cases are labeled correctly with allergen information that says the product contains peanuts.

The products included in the recall are 20 pack units that contain six-piece sleeves and have “best when used by” dates of Jan. 8, 2026 and Jan. 15, 2026.

The items also have an “AE” plant code on top of the package.

Photos of the impacted units can be seen on the FDA’s website, which says they were available at a limited number of retail stores as of Nov. 28.

The cases were sold in New York, New Jersey, Pennsylvania, Georgia, Arkansas, Missouri, Oklahoma, and Alabama.

No injuries or illness were reported to Mondelēz Global, the parent company of Ritz, as of Nov. 28.

Get Forbes Breaking News Text Alerts: We’re launching text message alerts so you’ll always know the biggest stories shaping the day’s headlines. Text “Alerts” to (201) 335-0739 or sign up here.

Big Number

4.6 million. That is approximately how many Americans have peanut allergies, according to a 2021 study in the Journal of Allergy and Clinical Immunology.

Read More

Source: https://www.forbes.com/sites/antoniopequenoiv/2025/12/03/ritz-cracker-sandwiches-recalled-after-mislabeling-poses-threat-to-those-with-peanut-allergies/

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Is Doge Still The Best Crypto Investment, Or Will Pepeto Make You Rich In 2025

Is Doge Still The Best Crypto Investment, Or Will Pepeto Make You Rich In 2025

The post Is Doge Still The Best Crypto Investment, Or Will Pepeto Make You Rich In 2025 appeared on BitcoinEthereumNews.com. Crypto News 18 September 2025 | 13:39 Is Dogecoin actually running out of gas, after making people millionaires overnight? As investors hunt for the best crypto to buy now and the best crypto to invest in 2025, Dogecoin still owns the meme spotlight, yet its upside looks capped according to today’s Dogecoin price prediction. Focus is shifting toward projects that marry community with real on chain utility. People searching best crypto to buy now want shipped products, audits, and transparent tokenomics. That frames the honest matchup for this cycle, Dogecoin versus Pepeto. Meet Pepeto, an Ethereum based meme coin built with live rails, PepetoSwap for zero fee trading and Pepeto Bridge for smooth cross chain moves. By blending story with tools people can touch today, and speaking directly to crypto presale 2025 demand, Pepeto puts utility, clarity, and distribution first. In a market where older meme coins risk drifting on sentiment, Pepeto’s delivery gives it a credible seat in the best crypto investment debate. First, here is why Dogecoin may be fading. Dogecoin Price Prediction Is Dogecoin Losing Momentum Remember when Dogecoin made crypto feel effortless. In 2013, Doge turned an internet joke into money and a movement that welcomed everyone. A decade later the market is tougher and the relentless tailwind is gone, sentiment is choppier and patience matters. With Doge near $0.268, the setup reads bearish to neutral for the next few weeks. If the $0.26 shelf holds on daily closes, expect choppy range trading toward $0.29 to $0.30 where rallies keep stalling. Lose $0.26 and momentum often slides into $0.245 with risk of a deeper probe toward $0.22 to $0.21. Close back above $0.30 and the downside bias is likely neutralized, opening room for a squeeze into the low $0.30s. Beyond the price view, Dogecoin still centers…
Share
BitcoinEthereumNews2025/09/18 18:56